Volatility of vaccine confidence.
Heidi J Larson 
;
David ABroniatowski;
(2021)
Volatility of vaccine confidence.
Science (New York, N.Y.), 371 (6536).
1289-.
ISSN 0036-8075
DOI: 10.1126/science.abi6488
;
David ABroniatowski;
(2021)
Volatility of vaccine confidence.
Science (New York, N.Y.), 371 (6536).
1289-.
ISSN 0036-8075
DOI: 10.1126/science.abi6488
<jats:p>Last week, the European Medicines Agency declared the AstraZeneca COVID-19 vaccine safe and effective, after several European Union member states had suspended its use because of blood clot concerns. Will the public trust this message? This week's news could help—a U.S. phase 3 clinical trial of the vaccine shows promising efficacy in preventing symptomatic COVID-19. But sentiments toward vaccines are volatile and reflect external events—such as recent concern about AstraZeneca's efficacy data—as well as internal emotions.</jats:p>
-
picture_as_pdf - Larson_Broniatowski_2021_Volatility-of-vaccine-confidence.pdf
-
subject - Accepted Version
-
- Available under Creative Commons: NC-ND 3.0
Explore Further
Read more research from the creator(s):
Find work associated with the faculties and division(s):
Find work associated with the research centre(s):
Find work from this publication: